This week we talk about HIV, AIDS, and ART.We also discuss HAART, the Berlin Patient, and potential future cures.Recommended Book: Allergic by Theresa MacPhailShow Notes* https://www.unaids.org/en/resources/fact-sheet* https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-treatment-basics* https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-therapy-art* https://www.paho.org/en/topics/antiretroviral-therapy* https://journals.lww.com/jaids/fulltext/2010/01010/declines_in_mortality_rates_and_changes_in_causes.13.aspx* https://link.springer.com/article/10.1007/s13181-013-0325-8* https://academic.oup.com/jac/article/73/11/3148/5055837?login=false* https://journals.lww.com/jaids/fulltext/2016/09010/narrowing_the_gap_in_life_expectancy_between.6.aspx* https://en.wikipedia.org/wiki/Tenofovir_disoproxil* https://en.wikipedia.org/wiki/Management_of_HIV/AIDS* https://www.verywellhealth.com/cart-hiv-combination-antiretroviral-therapy-48921* https://www.cdc.gov/hiv/risk/art/index.html* https://www.freethink.com/health/cured-of-hiv* https://www.jstor.org/stable/3397566?origin=crossref* https://www.nytimes.com/1982/05/11/science/new-homosexual-disorder-worries-health-officials.html* https://pubmed.ncbi.nlm.nih.gov/23444290/* https://my.clevelandclinic.org/health/diseases/4251-hiv-aids* https://web.archive.org/web/20080527201701/http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf* https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00028-0/fulltextTranscriptIn mid-May of 1981, the queer community-focused newspaper, the New York Native, published what would become the first-ever article on a strange disease that seemed to be afflicting community members in the city.What eventually became known as AIDS, but which was at the time discussed by medical professionals primarily in terms of its associated diseases, was clinically reported upon for the first time less than a month later, five official cases having been documented in an interconnected group of gay men and users of injectable drugs, who came to the attention of doctors for not being inherently immunocompromised, but still somehow contracting a rare type of pneumonia that only really impacted folks with severely impaired immune systems.In subsequent years, doctors started using a range of different terms for HIV and AIDS, calling them at different times and in different contexts the lymphotophic retrovirus, Kaposi's sarcoma and opportunistic infections, and the 4H disease, referring to heroine users, hemophiliacs, homosexuals, and Haitians, the four groups that seemed to make up almost all of the confirmed afflicted patients.The acronym GRID, for gay-related immune deficiency was also used for a time, but that one was fairly rapidly phased out when it became clear that this condition wasn't limited to the gay community—though those earlier assumptions and the terminology associated with them did manage to lock that bias into mainstream conversation and understanding of AIDS and HIV for a long time, and in some cases and in some locations, to this day.By the mid-80s, two research groups had identified different viruses that seemed to be associated with or responsible for cases of this mysterious condition, and it was eventually determined (in 1986) that they were actually the same virus, and that virus was designated HIV.HIV, short for Human Immunodeficiency Virus, is a retrovirus that, if left untreated, leads to Acquired Immunodeficiency Syndrome, or AIDS, in about 50% of patients within ten years of infection.So HIV is the virus, AIDS is a condition someone with HIV can develop after their immune system is severely damaged by the infection, and there are a bunch of diagnostic differentiations that determine when someone has transitioned from one category to the other, but in general folks with HIV will experience moderate flu- or mono-like symptoms, alongside swollen lymph nodes and rashes and throat problems and sores across their bodies in the early stages of infection, and as things progress, they develop opportunistic infections of the kind that can only really latch onto a human when their immune system is weakened or shut down. While AIDS, arriving after the immune system is well and truly damaged, brings with it a slew of opportunistic infections and associated issues, the afflicted person potentially developing all sorts of cancers, sarcomas, persistent infections, and extreme versions of the flu-like, mono-like symptoms they may have suffered earlier on.We don't know for certain how and where HIV originated—and that's true of both kinds, as there's an HIV-1 and HIV-2 virus, the former of which accounts for most infections, the latter of which is less common, and less overall infectious—but both HIV types seem to have been transmitted to humans from non-human primates somewhere in West-central Africa in the early 20th century, possibly from chimpanzees in southern Cameroon, but that's pretty speculative, and there's some evidence that these diseases may have made the leap several times; so while there's a pretty good chance, based on what we know now, that the disease made it into humans and mutated approximately somewhere in that vicinity, sometime in the early 20th century, possibly via chimps hunted and eaten by locals as bushmeat, we really don't know for certain.There are reports of what were probably HIV as far back as 1959 in the Belgian Congo, but that's a bit speculative, too, and based on imperfect notes from the time.Back then, though, and through the 1980s, folks who contracted HIV and who were not treated would typically die within 11 years of being infected, and more than half of those diagnosed with AIDS in the US from 1981 through 1992 died within 2 years of their diagnosis; such a diagnosis was a death sentence, basically; it was a really horrible and scary time.Today, the outlook for folks who contract HIV is substantially better: the life expectancy of someone who contracts the virus and who is able to get treatment is about the same as someone who is not infected; the disease isn't cured, but the level of HIV virus in the blood of a person receiving treatment is so small that it's no longer transmissible, or even detectable.What I'd like to talk about today is a new therapy that's making those sorts of outcomes possible, how some few people have now been cured of HIV entirely, and what's on the horizon in this space.—Antiretroviral therapy, or ART, typically consists of a combination of drugs based on those that were originally combined in this way in 1996 by researchers who announced their findings at the International AIDS Conference in Vancouver—they called their approach highly active antiretroviral therapy, or HAART, and this combo was based on findings from earlier drugs that addressed one of HIV's seven stages of development—but because they all hit that same, single stage, the virus was rapidly developing an immunity to them, and they were universally pretty toxic, with horrible side-effects.What's more, this drug cocktail increased patients' life expectancy by about 24 months, on average—which is a lot, about two years, but considering all those side effects, which included severe liver problems and anemia, the extra months of life generally weren't very pleasant extra months.In 1995, a class of drugs called protease inhibitors were introduced, which prevented HIV from making copies of itself using the body's structural proteins.That, combined with the effects of other, existing retrovirals, which hindered the virus's ability to hijack the body's cells to make more of itself, turned out to be a substantial improvement over just one or the other approach.The announcement in 1996 was notable because the researchers involved were able to knock the viral load in their patients down to an undetectable level, and then keep it there, by using three drugs from each of those two antiviral classes, those two different approaches.So HAART was a major improvement over what came before, but it was still imperfect; deaths tied to HIV plummeted by 50% in the US and Europe in just three years, but the life expectancy of folks using this therapy was still low compared to other people; someone who contracted HIV in their 20s and went on this therapy was still only expected to live till their early 50s; way better than a two-year increase, but still plenty of room for improvement.In addition to that lifespan duration limitation, the HAART bundle of therapies was just really difficult to maintain.Some people experienced a dramatic redistribution of body fat, some developed heart arrhythmias or insulin resistance or peripheral neuropathy or lactic acidosis—which is basically a toxic buildup of the acid that results from metabolism, which is usually cleared naturally, but when it doesn't, it's potentially deadly.Anything less than absolutely perfect adherence to the treatment schedule was also potentially deleterious to the desired outcomes; it wasn't a forgiving regimen, with some of the drugs requiring three capsules be taken every 8 hours, and there was a chance that if a portion of a dose of one drug was missed, or not administered on time, the virus could develop an immunity to it and the whole thing would fall apart.Consequently, the HAART regimen was generally reserved until things got really bad, and that meant it didn't have a very large effect on the infected population, and those who did benefit from it suffered consequences, alongside those benefits.The change in terminology from HAART to ART arrived in 2001 when a drug called Viread, the brand name for tenofovir disoproxil, was released and added into the mix, replacing some of the most toxic and cumbersome of the previous therapies with a single pill per day, and one that came with far fewer, and far less extreme, side effects.In 2005 it was finally demonstrable, with a bunch of data, that beginning this type of therapy early rather than waiting until things get really bad was worth the trade-offs—researchers showed that if folks received access to ART upon diagnosis, severe HIV associated and non HIV associated illnesses were reduced by 61%.As of 2016 there was still an average life expectancy gap between folks with HIV who received early care and people who were not infected of about 8 years, but that gap has been steadily closing with the introduction of new, easier to use, less side effect prone drugs—drugs that tend to attack the virus at different stages, and which take different approaches to hindering and blocking it—alongside innovations in how the drugs are delivered, like introducing substances that are converted by the body into the desired drug, which massively cuts the requisite dosage, in turn lessening the strain on the body's organs and the potential side effects associated with taking a higher dose of the drug, itself.We've also seen the advent of fixed-dose combination drugs, which are exactly what they sound like: a single pill containing the entire combination of drugs one must take each day, which makes a combination therapy much easier to administration and stick with, which in turn has substantially reduced the risk of severe side effects, and prevented mutations that might otherwise make a patient's virus more immune to some component of the drug cocktail.Some newer options just use two drugs, too, compared to the previous three-or-more, and most of these have been shown to be just as effective as the earlier, more bodily stressful combinations, and a recent, 2021 drug is injectable, rather than deliverable in pill-form, and can be administered just once a month—though a version of this drug, sold under the name Cabenuva, has been approved for administration every other month.So things in this corner of the medical world are looking pretty good, due new approaches and innovations to existing therapy models.These models remain imperfect, but they're getting better every year, and contracting HIV is no longer a death sentence, nor does it mean you'll always be infectious, or even detectably infected: the amount of HIV virus in one's blood can be kept undetectably low for essentially one's entire life, so long as one is able to get on the right therapy or combination of therapies and stick with it.That said, the global HIV pandemic is far from over, and access to these drugs–many of which are pricy, if you don't have insurance that will cover them—is not equally distributed.As of late-2022, the UN's official numbers indicate that about 39 million people, globally, have HIV, about 1.3 million were infected in 2022, and about 630,000 died from AIDS-related illnesses that year.That said, of those 39 million or so who are infected, nearly 30 million are receiving some kind of antiretroviral therapy, and about 86% of people who are estimated to be infected know their status, so they can seek such therapies, and/or take other precautious to protect themselves and others; though that also means about 5.5 million people, globally, have HIV and don't realize it.Here's a really remarkable figure, though: among people who are infected and know they are infected, about 93% of them were virally suppressed as of 2022.That's astonishing; 93% of people who have HIV and are aware of it are on some kind of therapy that has allowed them to suppress the virus so that it's nearly undetectable—the difference between the two, by the way, is that suppressed means 200 copies of the HIV virus per milliliter of blood, while undetectable is generally considered to be less than 50 copies per milliliter.So huge leaps in a relatively short period of time, and a massive improvement in both duration and quality of life for folks who might otherwise suffer mightily, and then die early, because of this virus and its associated symptoms.That said, there are some interesting, new approaches to dealing with HIV on the horizon, and some of them might prove to be even more impactful than this current batch of incredibly impactful ART options.As of September 2023, five people have been confirmed cured of HIV; not suppressed and not with viral loads at undetectable levels: cured.The first of these cured people, often referred to as the Berlin Patient, received a stem cell transplant from a bone marrow donation database that contained a genetic mutation called CCR5 Delta 32, which makes those who have it essentially immune to HIV infection.Three months after he received the transplant and stopped taking ART, doctors were unable to find any trace of the virus in his blood.He died from cancer in 2020, but there didn't seem to be any HIV in his blood from when he received the stem cell transplant, onward, and that happened in the early 2000s, and was formally announced to the medical community in 2008.At least two other people—two that we know about, anyway—have been cured of HIV using the same method; though at the moment at least, this option is severely limited as it requires that patients have a bone marrow match in donor databases, and that one of those donors have that specific, relatively rare mutation; so with existing science and techniques, at least, this is unlikely to be a widespread solution to this problem—though a 2017 experiment used stem cells derived from umbilical cord blood from a baby with that mutation to treat a woman' leukemia and cure her HIV, so there's a chance other approaches that make use of the same basic concept might be developed, opening this up to more people.Cancer drugs may also help some people with HIV: a drug that's been approved to treat several cancers called Venetoclax seems to also bind to a protein that helps HIV-infected T cells dodge the body's immune system and survive, and that realization has led to a series of experiments that showed HIV was suppressed in mice receiving this drug—though it bounced back a week later, and two weeks later in mice receiving both this drug and ART.This is unlikely to be a solution unto itself, then, but there's a chance either an adjusted version of this drug, or this drug in combination with other therapies, might be effective; and there's a clinical trial testing the efficacy of Venetoclax in human HIV patients at the end of this year, and another in 2024, so we may soon know if its safe and desirable to use this drug alongside ART, and that may, in turn, lead to a better understanding of how to amplify the drug's effects, or apply this method of hindering HIV from a different angle.CRISPR, the gene-editing technology borrowed from bacteria that allows for the cutting and removing and adding of genetic information, has enabled the development of several new potential HIV cures, one of which, called EBT-101, basically enters the body, finds helper T cells, and then cuts out chunks of the HIV virus's DNA, which prevents it from being able to replicate itself or hide away, reemerging later after another treatment has suppressed it.The benefit of this approach is that it could kill the viral reservoirs that otherwise allow HIV to persist in people who have undergone treatments, and a version of it that targets SIV, which is similar to HIV, but found in non-human primates—performed exactly as they hoped it would, finding and editing the targeted DNA, raising hopes than an HIV-targeting variation may manage similar wonders in human patients.This would be great if it ends up working, as one injection would theoretically clear all HIV from a person's system in relatively short-order, but the trials done so far have been small and on monkeys, and because of the nature of the research, it's not clear the monkeys were cured of HIV—just that the treatment got where it was supposed to go and made some DNA edits.A human trial of EBT-101 will finish up in March of 2025, though the researchers plan to follow up with their subjects for up to 15 years following the trial, to assess any long-term effects from their treatment, since CRISPR and this approach to messing with genes is still such a new thing.So while this may be a solution at some point, there's a good chance it won't be a real-deal, available option for another decade, minimum.So we've come a long way in a very short period of time with HIV and AIDS treatments, and the future is looking pretty good, with even more options and approaches on the horizon, including some actual cures, alongside high-quality, actually useable treatments.But there's still room to grow in terms of infection awareness, there are still distribution issues for some of these drugs, and there's still a fair bit of prejudice, the consequence of ignorance and historical misunderstandings and biases, keeping folks and institutions from doing as much as they otherwise could in many parts of the world; so a lot to be proud of, a lot to look forward to, but still plenty of room for improvement across the board. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
Five Americans detained in Iran are free and on their way to the United States, as part of a US-Iran agreement, which also includes the release of $6 billion in Iranian funds for humanitarian use. Christiane is joined by US National Security spokesperson John Kirby, and later by Jared Genser, who represents former detainee Siamak Namazi. As world leaders gather in New York for the United Nations General Assembly, they face cascading challenges – from the war in Ukraine to the critical climate crisis. Christiane sat down with UN Secretary General António Guterres. 20 years ago, President Bush introduced one of the United States's most successful foreign aid programs, PEPFAR. The plan for AIDS relief has saved 25 million lives but is now under threat. House Republicans are opposing funding for it, which expires at the end of the month, over abortion politics. Steven Thrasher is a HIV and AIDS scholar and joins the show to discuss the global impact of this relief.To learn more about how CNN protects listener privacy, visit cnn.com/privacy
In In Visible Archives: Queer and Feminist Visual Culture in the 1980s (U Minnesota Press, 2023), Margaret Galvan explores a number of feminist and cultural touchstones—the feminist sex wars, the HIV/AIDS crisis, the women in print movement, and countercultural grassroots periodical networks—and examines how visual culture interacts with these pivotal moments. She goes deep into the records to bring together a decade's worth of research in grassroots and university archives that include comics, collages, photographs, drawings, and other image-text media produced by women, including Hannah Alderfer, Beth Jaker, Marybeth Nelson, Roberta Gregory, Lee Marrs, Alison Bechdel, Gloria Anzaldúa, and Nan Goldin. Through all of this, Galvan documents the community networks that produced visual culture, analyzing how this material provided a vital space for women artists to theorize and visualize their own bodies and sexualities. The art highlighted in In Visible Archives demonstrates how women represented their bodies and sexualities on their own terms and created visibility for new, diverse identities, thus serving as blueprints for future activism and advocacy—work that is urgent now more than ever as LGBTQ+ and women's rights face challenges and restrictions across the nation. Jen Hoyer is Technical Services and Electronic Resources Librarian at CUNY New York City College of Technology. Jen edits for Partnership Journal and organizes with the TPS Collective. She is co-author of What Primary Sources Teach: Lessons for Every Classroom and The Social Movement Archive. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies
In In Visible Archives: Queer and Feminist Visual Culture in the 1980s (U Minnesota Press, 2023), Margaret Galvan explores a number of feminist and cultural touchstones—the feminist sex wars, the HIV/AIDS crisis, the women in print movement, and countercultural grassroots periodical networks—and examines how visual culture interacts with these pivotal moments. She goes deep into the records to bring together a decade's worth of research in grassroots and university archives that include comics, collages, photographs, drawings, and other image-text media produced by women, including Hannah Alderfer, Beth Jaker, Marybeth Nelson, Roberta Gregory, Lee Marrs, Alison Bechdel, Gloria Anzaldúa, and Nan Goldin. Through all of this, Galvan documents the community networks that produced visual culture, analyzing how this material provided a vital space for women artists to theorize and visualize their own bodies and sexualities. The art highlighted in In Visible Archives demonstrates how women represented their bodies and sexualities on their own terms and created visibility for new, diverse identities, thus serving as blueprints for future activism and advocacy—work that is urgent now more than ever as LGBTQ+ and women's rights face challenges and restrictions across the nation. Jen Hoyer is Technical Services and Electronic Resources Librarian at CUNY New York City College of Technology. Jen edits for Partnership Journal and organizes with the TPS Collective. She is co-author of What Primary Sources Teach: Lessons for Every Classroom and The Social Movement Archive. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/art
In In Visible Archives: Queer and Feminist Visual Culture in the 1980s (U Minnesota Press, 2023), Margaret Galvan explores a number of feminist and cultural touchstones—the feminist sex wars, the HIV/AIDS crisis, the women in print movement, and countercultural grassroots periodical networks—and examines how visual culture interacts with these pivotal moments. She goes deep into the records to bring together a decade's worth of research in grassroots and university archives that include comics, collages, photographs, drawings, and other image-text media produced by women, including Hannah Alderfer, Beth Jaker, Marybeth Nelson, Roberta Gregory, Lee Marrs, Alison Bechdel, Gloria Anzaldúa, and Nan Goldin. Through all of this, Galvan documents the community networks that produced visual culture, analyzing how this material provided a vital space for women artists to theorize and visualize their own bodies and sexualities. The art highlighted in In Visible Archives demonstrates how women represented their bodies and sexualities on their own terms and created visibility for new, diverse identities, thus serving as blueprints for future activism and advocacy—work that is urgent now more than ever as LGBTQ+ and women's rights face challenges and restrictions across the nation. Jen Hoyer is Technical Services and Electronic Resources Librarian at CUNY New York City College of Technology. Jen edits for Partnership Journal and organizes with the TPS Collective. She is co-author of What Primary Sources Teach: Lessons for Every Classroom and The Social Movement Archive. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/critical-theory
In In Visible Archives: Queer and Feminist Visual Culture in the 1980s (U Minnesota Press, 2023), Margaret Galvan explores a number of feminist and cultural touchstones—the feminist sex wars, the HIV/AIDS crisis, the women in print movement, and countercultural grassroots periodical networks—and examines how visual culture interacts with these pivotal moments. She goes deep into the records to bring together a decade's worth of research in grassroots and university archives that include comics, collages, photographs, drawings, and other image-text media produced by women, including Hannah Alderfer, Beth Jaker, Marybeth Nelson, Roberta Gregory, Lee Marrs, Alison Bechdel, Gloria Anzaldúa, and Nan Goldin. Through all of this, Galvan documents the community networks that produced visual culture, analyzing how this material provided a vital space for women artists to theorize and visualize their own bodies and sexualities. The art highlighted in In Visible Archives demonstrates how women represented their bodies and sexualities on their own terms and created visibility for new, diverse identities, thus serving as blueprints for future activism and advocacy—work that is urgent now more than ever as LGBTQ+ and women's rights face challenges and restrictions across the nation. Jen Hoyer is Technical Services and Electronic Resources Librarian at CUNY New York City College of Technology. Jen edits for Partnership Journal and organizes with the TPS Collective. She is co-author of What Primary Sources Teach: Lessons for Every Classroom and The Social Movement Archive. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network
The former president is among a group of establishment Republicans working to convince anti-abortion groups and conservatives to support reauthorizing the global HIV/AIDS program. Host Alice Miranda Ollstein talks with POLITICO global health care reporter Carmen Paun about the last-ditch effort.
The lawyer and longtime community organizer talks about her two-year ban from practicing immigration law, how she is responding to it, and her history of border organizing and advocacy in Arizona. In July the Board of Immigration Appeals ordered that prominent federal immigration lawyer and longtime community organizer Margo Cowan be barred for two years from practicing law in immigration court for “violating the rules of professional conduct.” For this week's podcast interview, The Border Chroniclecaught up with Cowan in her Tucson office to hear her side of the story. This story includes Cowan's long history of advocacy and organizing in the community—including know-your-rights campaigns in Tucson in the 1970s, work with the Sanctuary Movement and HIV/AIDS awareness in the 1980s, and working for the Tohono O'odham Nation in the 1990s, where she witnessed the onset of border militarization on the native reservation that, she asserts, has now become an “occupied” territory. (By the way, here is the link to Cowan's book about the Tohono O'odham, cowritten with historian Guadalupe Castillo. We mention the book in the podcast). Throughout the conversation, Cowan talks about her work as a public defender, work that led to the founding of the organization Keep Tucson Together in 2011. KTT is a pro bono legal clinic whose mission is to stop deportations and family separations in southern Arizona. In the interview, Cowan explains the two-year ban and how she is appealing the ruling, and she vividly describes just how intimidating immigration court is. “I hate immigration court,” she says. “I hate what they do to our community. I hate the fact that they are cloaked in some quantum of respectability. But, having said that, people need representation.” --- Support this podcast: https://podcasters.spotify.com/pod/show/border-chronicle/support
This episode discusses four MMWR reports. First, despite very low risk of getting malaria in the U.S., locally acquired malaria cases reported in Florida and Texas highlight importance of quick diagnosis, treatment, and malaria prevention methods. Second, more than 33 million children in Africa are missing a measles vaccine, highlighting the urgent need to increase immunization efforts to prevent outbreaks and deaths. Third, the JYNNEOS vaccine offers protection against hospitalization among people with mpox, including people with HIV. Finally, norovirus was the main cause of illness among more than two dozen hikers on Washington's Pacific Crest Trail.
This episode discusses four MMWR reports. The most recent data from 2020 and 2021 were examined to determine the percentage of older adults who reported falling during the previous year and unintentional fall-related death rates. In 2020, approximately 14 million older adults reported falling during the past year. In 2021, nearly 39,000 older adults died due to an unintentional fall, which is about 100 older adults per day dying from falls. Older women were more likely to report a fall than older men, while older men had higher fall death rates.
Embodiment for the Rest of Us - Season 3, Episode 10: Whitney Trotter Chavonne (she/her) and Jenn (she/her) interviewed Whitney Trotter (she/her) about their embodiment journey. Whitney Trotter (she/her) is dually licensed as a Registered Dietitian, Nurse, and yoga instructor and is currently working on her doctorate degree to become a psychiatric nurse practitioner. Whitney has over ten years of experience working as a registered dietitian serving various communities such as the HIV/AIDS community and the eating disorder field. Whitney also previously worked at a Level 1 Pediatric Trauma Center as a Pediatric emergency room nurse. In addition to working as an RDN and RN, Whitney has served as a member of her county's Rape Crisis Center. Her work at the Rape Crisis Center equipped her to co-found an anti-trafficking organization Restore Corps, where she now provides medical training to the community focusing on human trafficking response. Whitney's career in the Eating Disorder field includes being a former Nutrition and Nursing director of a Residential, PHP, and IOP center. Whitney is also the owner/founder of Bluff City Health, a private practice that bridges the gap in the eating disorder field of equitable care and social justice. This past year Whitney created the first-ever BIPOC Eating Disorders Conference and started #BIPOCEatingDisordersAwarenessWeek Content Warning: discussion of privilege, discussion of diet culture, discussion of fatphobia, discussion of racism, discussion of fatphobia in the career space, discussion of mental health, discussion of chronic medical issues Trigger Warnings: None for this episode The captions for this episode can be found at https://embodimentfortherestofus.com/season-3/season-3-episode-10-whitney-trotter/#captions A few highlights: 4:21: Whitney shares her understanding of embodiment and her own embodiment journey 8:10: Whitney discusses how the pandemic affected her embodiment practices 14:26: Whitney shares her understanding of “the rest of us” and how she is a part of that, as well as her privileges 24:46: Whitney discusses how the word “Rest” right in the middle of the podcast name feels, occurs, and shows up for her 43:58: Whitney shares how her education and career have changed and challenged her relationship with her own embodiment 51:18: Whitney discusses her process in co-creating the BIPOC Eating Disorders Conference 1:10:31: Whitney shares her experience learning and unlearning while calling out what is oppressive in our systems 1:19:27: Whitney discusses how listeners can make a difference based on this conversation 1:26:05: Whitney shares where to be found and what's next for her Links from this episode: Ableism Angela Goens BIPOC Eating Disorders Conference Body Trust Fatness Spectrum Intersectionality Marquisele Mercedes Relative Fat vs. Absolute Fat Tiana Dodson Music: “Bees and Bumblebees (Abeilles et Bourdons), Op. 562” by Eugène Dédé through the Creative Commons License Please follow us on social media: Website: embodimentfortherestofus.com Twitter: @embodimentus Instagram: @embodimentfortherestofus
Tim Murphy is the author of Correspondents and Christodora, which was long-listed for the 2017 Andrew Carnegie Medal for Excellence in Fiction and named a Best Book of the Year by The Guardian. He has also been a journalist for the past 25 years and joined me on Uncorking a Story to talk about his career and latest novel, Speech Team. Key Takeaways Tim Murphy's passion for writing: Throughout the conversation, Tim shares his unwavering dedication to writing and his journey as an author. Listeners will learn about his personal reflections on the impact of a beloved teacher, his struggles and break from fiction writing, and the lasting impact of HIV/AIDS on his life and work. The inspiration behind "Speech Team": Tim discusses his novel, "Speech Team," which explores the lives of four friends from high school. Listeners will gain insights into the personal experiences and memories that influenced the book, as well as the process of excavating one's past for storytelling. Nostalgic reflections on pop culture: Tim takes a trip down memory lane, sharing nostalgic memories of childhood movies and the appeal of diva shade in 80s television repeats. Listeners will enjoy these moments of reflection and may find connections to their own experiences. The importance of personal growth and change: Tim discusses personal growth and change, both in his own life and in the lives of the characters in his novel. Listeners will gain insights into the transformative power of self-reflection and the impact of personal experiences on shaping one's identity. Buy Speech Team Amazon: https://amzn.to/3siApcD Bookshop.org: https://bookshop.org/a/54587/9780593653845 Connect With Tim Twitter: https://twitter.com/timmurphynyc?lang=en Instagram: https://www.instagram.com/timmurphynycwriter/ Connect with Mike Website: https://uncorkingastory.com/ Youtube: https://www.youtube.com/channel/UCSvS4fuG3L1JMZeOyHvfk_g Instagram: https://www.instagram.com/uncorkingastory/ TikTok: https://www.tiktok.com/@uncorkingastory Twitter: https://twitter.com/uncorkingastory Facebook: https://www.facebook.com/uncorkingastory LinkedIn: https://www.linkedin.com/company/uncorking-a-story/ If you like this episode, please share it with a friend. If you have not done so already, please rate and review Uncorking a Story on Apple Podcasts, or wherever you get your podcasts. #TimMurphy #AuthorInterview #NovelistLife #WritingPassion #SpeechTeam #AutobiographicalNovel #PersonalGrowth #LGBTQVisibility #NostalgicMemories #DivaShade #80sTelevision #Choreography #ChildhoodMovies #BoxingMovie #WritingJourney #UncorkingAStory #PodcastInterview #TimMurphyNYCWriter #ConnectWithTheAuthor #BuySpeechTeam #FindTimMurphy #AuthorWebsite #InstagramWriter #LiteraryCommunity #BookLovers #ReadersofInstagram #SupportAuthors #UncorkYourStory #PodcastRecommendation #MustListen Learn more about your ad choices. Visit megaphone.fm/adchoices
The Sierra Club is one of the oldest and largest environmental groups in the U.S.. It also has a problematic history, from being founded by racist John Muir to members penning the racist "Population Bomb," advocating for population control, to former director Carl Pope promoting corporate greenwashing. Earlier this year, politician Ben Jealous became the organization's new executive director and began a process of "restructuring" due to budget deficits. The restructuring led to layoffs that included the equity and environmental justice teams. We talk with Hop Hopkins and Michelle Mascarenhas (@MG_MMS), two of the top directors, laid off in the Sierra Club's restructuring about what happened, the impacts on environmental organizing and equity within the non-profit industrial complex. Bios// Hop Hopkins is the former Director of Organizational Transformation at the Sierra Club, where he helped the organization evolve its commitment to anti-racism. Hop is a longtime social movement strategist and scholar, and has been a leader in movements from HIV/AIDS to anti-globalization, food sovereignty, anti-displacement and clean energy transition, after beginning his career as a grassroots environmental justice community organizer. Most recently he was a Climate Justice Fellow and adjunct professor at Antioch University. He is based on Tongva land in Los Angeles, CA. Michelle Mascaranehas is the former National Director of Campaigns at the Sierra Club. Before coming to the Sierra Club, Michelle was a co-director of Movement Generation Justice & Ecology Project where she supported the formation of the Climate Justice Alliance, the Reclaim Our Power Utility Justice Project, and projects at the intersection of land, Indigenous sovereignty, reparations and Black liberation. Prior to her time at MG, Michelle worked as a union organizer and organized farm-to-school projects. Michelle is based on Chochenyo Ohlone land in Berkeley, CA. ------------------------------------------ Outro- "Wade in the Water" by the Fisk Jubilee Singers Links// +Convergence: Laid-off Sierra Club Staffers: ‘We Can't Give Up on United Fronts' (https://bit.ly/3ZnVDlF) +The New Republic: What the Hell is Going on at the Sierra Club (https://bit.ly/3RlEHu7) +WaPo:The Sierra Club hired its first Black leader. Turmoil over racial equity followed. (https://bit.ly/45MswuT) Follow Green and Red// +G&R Linktree: https://linktr.ee/greenandredpodcast +Our rad website: https://greenandredpodcast.org/ Support the Green and Red Podcast// +Become a Patron at https://www.patreon.com/greenredpodcast +Or make a one time donation here: https://bit.ly/DonateGandR This is a Green and Red Podcast (@PodcastGreenRed) production. Produced by Bob (@bobbuzzanco) and Scott (@sparki1969). “Green and Red Blues" by Moody. Editing by Isaac.
In this episode of the Darin Olien show, we will explore the need for collective responsibility in dealing with various societal issues, primarily the extent of corporate influence on US policy decisions, and how individual action alone is not sufficient to bring about meaningful change. My guest Marianne Williamson explains how the power of collective action is being underestimated and should be leveraged more effectively to challenge corporate influence and advocate for social justice. My hope with this episode is to highlight the urgent need our country has for radical change and the crucial role each person plays in shaping the world around us. Plus, the importance of electing a president who is willing to challenge the corporate duopoly and stand up against corporate interests. Marianne Williamson is a bestselling author, political activist, spiritual thought leader, and presidential candidate. For over three decades, she has been a leader in spiritual and religiously progressive circles. She is the author of 15 books, four of which have been #1 New York Times bestsellers. Williamson founded Project Angel Food, a non-profit organization that has delivered more than 16 million meals to ill and dying homebound patients since 1989. The group was created to help people suffering from the ravages of HIV/AIDS. She has also worked throughout her career on poverty, anti-hunger and racial reconciliation issues. In 2004, she co-founded The Peace Alliance and supported the creation of a U.S. Department of Peace. Williamson ran for the Democratic nomination for president in 2020 and is running for 2024. What we discuss: (0:00:08) - The importance of collective responsibility in creating significant change (0:05:00) - Corporate power in the United States (0:09:30) - The influence of corporate giants on the health of children and the elderly (0:11:51) - The impact of corporate power on economic injustice, highlighting issues such as food deserts and the influence of big companies on health (0:18:00) - The need for an education-induced awakening to challenge the status quo (0:24:05) - Corporate influence on US policy decisions to the 1800s (0:31:00) - The moment Marianne decided to run for president (0:35:31) - The urgent need for radical change in the face of economic disparity Thank you to our sponsors: Therasage: Go to www.therasage.com and use code DARIN at checkout for 15% off. Barukas: Head to barukas.com and use the code DARIN for 15% off your order. Find more from Marianne: Website: https://marianne2024.com/ X: @marwilliamson Facebook: https://www.facebook.com/williamsonmarianne/ Instagram: https://www.instagram.com/mariannewilliamson/ Find more from Darin: Website: https://darinolien.com/ Instagram: https://www.instagram.com/Darinolien/ Book: https://darinolien.com/fatal-conveniences-book/ Down to Earth: https://darinolien.com/down-to-earth/
At noon ET on Thursday Sept. 14, Epidemic host Céline Gounder and her guests will come together for a live web event. Click here to register for the event.In Conversation With Host Céline Gounder:Helene D. Gayle, a physician and an epidemiologist, is president of Spelman College. She is a board member of the Bill & Melinda Gates Foundation and past director of the foundation's program on HIV, tuberculosis, and reproductive health. She spent two decades with the Centers for Disease Control and Prevention focusing primarily on HIV/AIDS prevention and global health.William H. “Bill” Foege is an epidemiologist and a physician, and was a leader in the campaign to end smallpox during the 1970s. Foege is featured in Episode 2 of the “Eradicating Smallpox” docuseries.Submit your questions for the panel here.
Brad Guffey is Chief Medical Director at Family Legacy Missions International where he specializes in treating infectious diseases. Family Legacy is the ministry changing the lives of around 13,000 orphans in Zambia.They do that through a 4-part program: helping children grow academically, physically, emotionally, and spiritually. The physical and healthcare services that Family Legacy provides to Zambian children have grown tremendously in the last 10 years. Emphasis on pragmatism and efficiency in their approach.Belief in being faithful in small tasks.Acknowledgment of God's significant impact on their work and the lives of many children.Transformation from starting in a tent in a shipping container 10 years ago to a high-quality healthcare facility.Active service to several thousand families at any given time. What does medical care look like in Zambia?Zambia presents unique challenges with a population of 20 million, two-thirds of whom are under 25 years old.The challenges of healthcare in Zambia include efforts to prevent children from being left uncared for.Differences in healthcare include fewer prior authorizations but still dealing with paperwork.Seasonal rainy flooding affects access to homes, necessitating home visits.Various medical issues are highlighted, including opportunistic infections, cancers from advanced HIV/AIDS, tuberculosis, rheumatic fever, heart valve disease, liver cancer due to environmental toxins, and uncommon conditions like lymphatic worms and blood flukes.Routine medical problems are also common, often complicated by resource limitations, with severe malnutrition being a frequent issue, often stemming from poverty. Healthcare is absolutely essential before these amazing children can take on any other challenges.Emphasis on the essential role of healthcare for the 13,000 children in their program.A comprehensive approach to helping and caring for vulnerable and orphaned children in Zambia is highlighted.The mission is to glorify God by empowering these children to realize their God-given potential.Acknowledgment of the importance of good health for the children to thrive.Positive outcomes are observed, with children accessing modern medicine and receiving care from a dedicated team.Despite improvements and modernization, there are still cases where children arrive at the clinic in dire conditions.Brad shares an example about a child named Lydia, who overcame severe malnutrition, tuberculosis, seizures, and HIV, now living a healthier and happier life. To learn more and find out how you can help, visit HopeForZambia.com/faithfi. On today's program, Rob also answers listener questions: Does taking a loan from an insurance policy affect your credit? Should you put the name of an adult child on a property deed for estate planning purposes to help it pass more easily to them upon the death of the parent? Upon the death of a parent, does it make sense to sell the parent's home and split the proceeds with a sibling? What is the best way to start saving money for grandkids? Is a home equity line of credit a good way to pay for home improvements? Remember, you can call in to ask your questions most days at (800) 525-7000. Faith & Finance is also available on the Moody Radio Network as well as American Family Radio. Visit our website at FaithFi.comwhere you can join the FaithFi Community, and give as we expand our outreach.
Activists hold demonstration in House Speaker Kevin McCarthy's office over HIV-AIDS funding. Election deniers tout new AI tool as a way to promote election integrity. And a Bernalillo County Sheriff opposes Gov. Lujan Grisham's order on firearms.
In this episode of the Through Conversations podcast, join us for a deep dive into Marianne Williamson's presidential campaign as she discusses her motivations for running, her strategies to address existential challenges, her stance on international conflicts like the Russia-Ukraine War, and her vision for a more peaceful world. Explore her insights on foreign policy, particularly in Latin America and concerning China, as well as her perspective on handling the Fentanyl crisis and the impact of Artificial Intelligence. Discover how a Williamson Presidency could transform American politics and envision a post-WIlliamson United States.Highlights00:00 Intro.00:53 Why is Marianne Running For President?05:00 How Will Marianne Address Existential Challenges We Face?8:35 Marianne's Stance on The Russia-Ukraine War15:25 How Would a Williamson Presidency Stop The Endless Wars?20:00 What Williamson Administration do to prevent a conflict with China?22:34 How to Approach The Taiwan Challenge?25:12 Marianne on Foreign Policy, Latin America.31:46 How To Solve The Fentanyl Crisis?36:28 Marianne on The Threat / Opportunity of Artificial Intelligence.41:02 How would a Williamson Presidency change politics?46:00 How would the United States look like after a Williamson Presidency?MARIANNE WILLIAMSON BIOMarianne Williamson is a bestselling author, political activist, and spiritual thought leader. For over three decades, she has been a leader in spiritual and religiously progressive circles. She is the author of 15 books, four of which have been #1 New York Times bestsellers. Williamson founded Project Angel Food, a non-profit organization that has delivered more than 14 million meals to ill and dying homebound patients since 1989. The group was created to help people suffering from the ravages of HIV/AIDS. She has also worked throughout her career on poverty, anti-hunger and racial reconciliation issues. In 2004, she co-founded The Peace Alliance and supports the creation of a U.S. Department of Peace. Williamson ran for the Democratic nomination for president in 2020.Marianne's Website: Marianne2024.comSocial Media:Twitter @MarWilliamsonInstagram: MarianneWilliamson-----Thank you for tuning in! If you enjoyed this episode, share it with a loved one.If you are listening on Apple Podcasts or Spotify, rate the show and write a review with your thoughts -- I do read what you write and it helps more than you think!// LINKS //Website: https://throughconversations.comNewsletter: https://throughconversations.ck.page/0c18d1ab61// SOCIAL //Twitter: https://twitter.com/thruconvpodcastInstagram: https://www.instagram.com/thruconvpodcast/?hl=enYouTube: https://www.youtube.com/channel/UCl67XqJVdVtBqiCWahS776g
For "Pride is the Opposite of Shame" (Season 3, Episode 7), which dropped Thursday, September 7, we called to the Bimah Founding Artistic Director of National Queer Theater Adam Odsess-Rubin. Based in New York City, Adam founded NQT in 2018 to provide a creative home for LGBTQ+ artists and showcase unheard voices within the community. We had an enlightening discussion about how the Jewish concept of Tikkun Olam, meaning "to repair the world", has shaped Adam's artistic mission and informed NQT's focus on uplifting marginalized queer stories. He shared insights into curating NQT's 5th Annual Criminal Queerness Festival this past June, which spotlighted Eastern European and Ukrainian LGBTQ+ artists. Adam also gave us a preview of exciting new NQT initiatives like Staging Pride, a free theatre education program for LGBTQ+ youth, and the Write It Out! playwriting workshop for people living with HIV/AIDS. Through these impactful programs and productions, Adam and his team at NQT are truly working to repair the world for LGBTQ+ communities. "On the Bimah: Spotlighting Jewish Theatre Artists" continues to illuminate the heart, soul, and diversity of contemporary Jewish theatre, guided by your host Danielle Levsky. This podcast is an Alliance for Jewish Theatre program, produced by Danny Debner and Danielle Levsky. Our theme music is by Ilya Levinson and Alex Koffman, and our logo is by Alize Francheska Rozsnyai.
Congress returns from its summer recess with a long list of tasks and only a few work days to get them done. On top of the annual spending bills needed to keep the government operating, on the list are bills to renew the global HIV/AIDS program, PEPFAR, and the community health centers program. Meanwhile, over the recess, the Biden administration released the names of the first 10 drugs selected for the Medicare price negotiation program. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Meena Seshamani, who leads the federal Medicare program, about how the drug price negotiation program will work. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too: Julie Rovner: JAMA Health Forum's “Health Systems and Social Services — A Bridge Too Far?” by Sherry Glied and Thomas D'Aunno. Alice Miranda Ollstein: The Washington Post's “Heat's Hidden Risk,” by Shannon Osaka, Erin Patrick O'Connor, and John Muyskens. Rachel Cohrs: The Wall Street Journal's “How Novartis's CEO Learned From His Mistakes and Got Help From an Unlikely Quarter,” by Jared S. Hopkins. Joanne Kenen: Politico's “How to Wage War on Conspiracy Theories,” by Joanne Kenen, and “Court Revives Doctors' Lawsuit Saying FDA Overstepped Its Authority With Anti-Ivermectin Campaign,” by Kevin McGill. Click here for a transcript of the episode. Hosted on Acast. See acast.com/privacy for more information.
Congress could miss the September 30 deadline to reauthorize PEPFAR, a law governing U.S. global HIV/AIDS relief, because of abortion disputes, threatening the program's future. Daniel Payne talks with POLITICO health care reporter Alice Miranda Ollstein about the potential cuts to the program if Congress can't reach an agreement by the end of the year.
Southasiasphere is our roundup of news events and analysis of regional affairs, now out every two weeks. If you are a member, you will automatically receive links to new episodes in your inbox. If you are not yet a member, you can still get episode links for free by signing up here. In this episode, we talk about the blocking of The Kashmir Walla and the state of media freedom in Kashmir, and the pushback against China's controversial new map plus Bhutan–China boundary talks. In “Around Southasia in 5 minutes” we talk about caste atrocities in Uttar Pradesh, India's path-breaking lunar and solar missions, the Taliban's ban on women visiting national parks in Afghanistan and the death of the Afghan female YouTuber Hora Sadat, pushback from the Editor's Guild of India against a proposed official fact-checking unit in Karnataka, an increase in HIV/AIDs cases in Sri Lanka, the deletion of acting BNP chairman Tarique Rahman's speeches from social media ahead of Bangladesh's elections, and a controversial Supreme Court judgment on child marriage in Nepal. For “Bookmarked”, we discuss Don't expect anything, a short film directed by Didier Nusbaumer that led to Myanmar's junta arresting the cast and director for insulting Buddhist monks. Episode notes: The Bajaur bombing, India's ban on rice exports, violence in Haryana and Gurugram and more: https://www.himalmag.com/bajaur-bombing-india-ban-rice-exports-communal-violence-haryana-gurugram-nuh-2023-rahul-gandhi-defamation/ Memories of Galwan Valley: https://www.himalmag.com/memories-of-galwan-valley-2020/ The Doklam dispute, Rahul Gandhi's conviction, repression of journalists in Bangladesh and beyond, and much more: https://www.himalmag.com/doklam-dispute-rahul-gandhi-conviction-repression-of-journalists-bangladesh/ Don't expect anything!: https://www.youtube.com/watch?v=PpRm4wZ5i2g
This episode discusses four MMWR reports. First, West Nile virus continues to be the most common mosquito-borne disease in the U.S., with almost 3,000 cases reported in 2021. Second, CDC releases its first-ever 'Sepsis Core Elements' to help hospitals strengthen their sepsis programs. Third, CDC publishes its 2023-24 influenza vaccination recommendations. Everyone 6 months and older should get their annual flu shot, ideally in September or October. Finally, CDC recommends a new preventive tool for severe respiratory syncytial virus, the leading cause of infant hospitalizations.
Episode 283: In this episode, we venture into a controversial and tragic chapter of Canada's legal history. It intertwines public health, personal relationships, and the weight of the law. We're talking about the history of HIV non-disclosure cases in Canada. Part of our journey takes us to the early 2000s, zeroing in on Johnson Aziga, a Ugandan-born Canadian resident. His name would soon become synonymous with a landmark legal battle challenging the boundaries of consent, deception, and responsibility. Aziga was diagnosed with HIV in 1996, but his numerous subsequent relationships would cast him into the national spotlight. Two women, specifically, would become central to his story: both entered into relationships with Aziga, and HIV-related complications tragically took both. The women's names are protected under publication bans, so we cannot speak to their biographies. Regardless, their untimely deaths would raise a storm of questions about trust, disclosure, and the duty one owes to their intimate partners. Aziga was convicted of murder and deemed a dangerous offender, but argued that his race and status as an immigrant weighed against him. In 2023, the murder convictions were overturned and replaced with manslaughter charges substituted in their place. NOTE: In this podcast, the names of survivors will be kept confidential, and initials or aliases will be used instead. Sources: A history of HIV/AIDS HIV 101: The History of HIV & AIDS in Canada - Freddie Magazine The legacy of the HIV/AIDS fight in Canada R v Cuerrier After Cuerrier | Publications - Canadian HIV/AIDS Legal Network African immigrant damnation syndrome: The case of Charles Ssenyonga 2006 CanLII 42798 (ON SC) | R. v. Aziga | CanLII 2007 CanLII 38 (ON SC) | R. v. Aziga | CanLII 2011 ONSC 4592 (CanLII) | R. v. Aziga | CanLII Canada: HIV “murderer” Aziga now also a “dangerous offender,” locked up for life HIV-positive man convicted of murder apologizes to victims 2014 HRTO 144 (CanLII) | Aziga v. Ontario (Community Safety and Correctional Services) | CanLII 2014 HRTO 1465 (CanLII) | Aziga v. Ontario (Community Safety and Correctional Services) | CanLII Court overturns murder convictions against Ontario man who gave two women HIV, killing them 2023 ONCA 12 (CanLII) | R. v. Aziga | CanLII Update — Canada: Murder convictions for HIV transmission reduced to manslaughter HIV Criminalization Criminal HIV Transmission Canada: Ontario leads the world in the over-criminalization of HIV non-disclosure Learn more about your ad choices. Visit megaphone.fm/adchoices
Clint Callahan is a seasoned social worker and therapist who has been working in the mental health field since 2000. Clint's professional background is diversified and robust. It spans business management, program design, team collaboration, along with crisis management, case management, and therapy. Clint works with diverse populations and has tackled a broad spectrum of issues, such as men's issues, women's issues, complications related to active/retired military personnel, trauma, HIV/AIDS, relationship problems, psychiatric disorders, and substance abuse. His wealth of experience makes him an expert in addressing various issues related to mental health. For more, go to https://www.smallchangesbigimpact.net/
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers HIV/AIDS psychiatry with special guests from two international settings to provide complementary perspectives on HIV psychiatry. Dr. Adriana Carvalhal, HIV Psychiatrist and Staff Psychiatrist at Scarborough Health Network in Canada and Dr. Leigh Van Den Heuvel, Psychiatrist and Associate Professor in the Department of Psychiatry, at Stellenbosch University in South Africa. The learning objectives for this episode are as follows: By the end of this episode, you should be able to… Understand the unique mental health needs of people living with HIV and the bidirectional relationship between HIV and mental health Identify HIV-specific mental health disorders and how to screen for these conditions Outline the overall approach to treatment for HIV patients with mental health disorders Guests: Dr. Adriana Carvalhal and Dr Leigh Van Den Heuvel Produced by: Saja Jaberi (MD), Kate Braithwaite (MD) and Gaurav Sharma (PGY5) Hosts: Kate Braithwaite (MD) and Gaurav Sharma (PGY5) Audio editing by: Gaurav Sharma (PGY5) Show notes by: Saja Jaberi (MD) and Gaurav Sharma (PGY5) Conflicts of Interest: Neither of our guests nor hosts have declared any conflicts of interest related to this topic. Generic names are used for all medications referenced. Contents: Introduction - 0:19 Learning objectives - 3:52 The bidirectional relationship between HIV and psychiatric illness - 4:24 Prevalence of psychiatric illness in HIV - 9:56 Screening for psychiatric illness in HIV populations - 12:11 HIV Associated Neurocognitive Disorder (HAND) - 19:27 Diagnostic Criteria - 20:19 Clinical Presentation & Etiology - 23:03 Risk Factors - 26:56 Screening Tools - 32:06 Treatment - 36:59 HIV Psychiatry case example - 39:48 Navigating the differential diagnosis - 41:44 Initial management & addressing comorbidities - 44:30 Drug-drug interactions between antiretroviral and psychiatric medications - 48:04 Review of learning objectives & final thoughts - 52:04 Outro - 55:55 Resources: Clinical Care Guidelines for Adults and Adolescents Living with HIV in Ontario, Canada (occguidelines.com) Estimates of HIV incidence, prevalence and Canada's progress on meeting the 90-90-90 HIV targets, 2020 - Canada.ca HIV and Clinical Depression https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/Professional-Topics/HIV-Psychiatry/FactSheet-Anxiety-2012.pdf https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/Professional-Topics/HIV-Psychiatry/FactSheet-CognitiveDisorder-2012.pdf International HIV Dementia Scale (IHDS) - Mental Health Screening - National HIV Curriculum (uw.edu)/ Liverpool HIV Interactions (hiv-druginteractions.org) References: Angelovich TA, Churchill MJ, Wright EJ, Brew BJ. New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment. Curr Top Behav Neurosci. 2021;50:3-39. doi: 10.1007/7854_2019_126. PMID: 32040843. Angelovich TA, Churchill MJ, Wright EJ, Brew BJ. New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment. Curr Top Behav Neurosci. 2021;50:3-39. doi: 10.1007/7854_2019_126. PMID: 32040843. Awori V, Mativo P, Yonga G, Shah R. The association between asymptomatic and mild neurocognitive impairment and adherence to antiretroviral therapy among people living with human immunodeficiency virus. South Afr J HIV Med. 2018 Apr 12;19(1):674. doi: 10.4102/sajhivmed.v19i1.674. PMID: 29707383; PMCID: PMC5913780. Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, Quan D, Maruff P, Brew B, Cysique LA. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review. Clin Infect Dis. 2016 Sep 1;63(5):687-693. doi: 10.1093/cid/ciw399. Epub 2016 Jun 19. PMID: 27325690; PMCID: PMC4981762. Clinical Care Guidelines for Adults and Adolescents living with HIV in Ontario, Canada. Clinical Care Guidelines for Adults and Adolescents Living with HIV in Ontario, Canada (occguidelines.com) Core Concepts - Screening for Mental Health Conditions - Basic HIV Primary Care - National HIV Curriculum (uw.edu) Cysique LA, Casaletto KB, Heaton RK. Reliably Measuring Cognitive Change in the Era of Chronic HIV Infection and Chronic HIV-Associated Neurocognitive Disorders. Curr Top Behav Neurosci. 2021;50:271-298. doi: 10.1007/7854_2019_116. PMID: 31559600. EACS Guidelines version 11.1, October 2022. Joska JA, Witten J, Thomas KG, Robertson C, Casson-Crook M, Roosa H et al. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa. AIDS and behavior. 2016 Aug 1;20(8):1621-1631. doi: 10.1007/s10461-016-1316-y Kolakowska A, Maresca AF, Collins IJ, Cailhol J. Update on Adverse Effects of HIV Integrase Inhibitors. Curr Treat Options Infect Dis. 2019;11(4):372-387. doi: 10.1007/s40506-019-00203-7. Epub 2019 Nov 16. PMID: 33380904; PMCID: PMC7758219. Robbins RN, Scott TM, Gouse H, Marcotte TD, Rourke SB. Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity. Curr Top Behav Neurosci. 2021;50:429-478. doi: 10.1007/7854_2019_117. PMID: 32677005. Rubin LH, Maki PM. Neurocognitive Complications of HIV Infection in Women: Insights from the WIHS Cohort. Curr Top Behav Neurosci. 2021;50:175-191. doi: 10.1007/7854_2019_101. PMID: 31396894. Southern African HIV Clinicians Society. Management of mental health disorders in HIV-positive patients. S Afr J HIV Med 2013; 14(4): 155 - 165 Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, Singh T, Aberg JA. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021 Dec 6;73(11):e3572-e3605. doi: 10.1093/cid/ciaa1391. Erratum in: Clin Infect Dis. 2021 Dec 08;: Erratum in: Clin Infect Dis. 2022 Nov 30;75(11):2052. PMID: 33225349. Turjanski, N., & Lloyd, G. (2005). Psychiatric side-effects of medications: Recent developments. Advances in Psychiatric Treatment, 11(1), 58-70. doi:10.1192/apt.11.1.58 Wang Y, Liu M, Lu Q, Farrell M, Lappin JM, Shi J, Lu L, Bao Y. Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis. Neurology. 2020 Nov 10;95(19):e2610-e2621. doi: 10.1212/WNL.0000000000010752. Epub 2020 Sep 4. PMID: 32887786. CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association. For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at email@example.com. For more information, visit our website at psychedpodcast.org.
In this session, It will seek to help guide you on how to respond to God’s Command and Commission, The quest for discovering and following God’s will and purpose for one’s life is often an illusion to many children of the Living God, Many believers resorts to imitating others and or live a hypocritical phantom life as they are tied down to daily engagements and undertakings of everyday life, It is hoped that discovering the reason for living your life with purpose is made easier. You will discover the purpose for which God design you and gain the confidence to fruitfully be where you belong, through the power of the Holy Spirit. You will be guided through a biblical process and principles to seeing exactly God’s intent for your unique being and person, as Gods design, where you will discover that It all began with God before the foundations of the earth. Ever since, before the fall of humanity, God has you in mind, and he designed you for a purpose and through a process, but as a result of the departure of humans from God, through disbelief, you became blind and were kept ignorant of His plans for you. However, you will discover that His Deep love and Great Mercy, God called you to salvation, you became a new creature and adopted as His Child, hence He qualified you, by being a new creature in His image, He desires for you to return and rediscover His plan and purpose for your life As He God Intended. Responding to Gods Command and Commission, is a call to be ready, Dressed for service fully equipped and Lacking in nothing as you Respond through Obedience, based on a biblical Principles, These herculean task by helping you identify your uniqueness within the body of Christ, and to enable you walk confidently and victoriously where you belong in the program of God through the enabling power of the Holy Spirit. Finally, through the Scriptures and the Power of the Holy Spirit, You will be exposed and guided to God’s Command and Commission, That you begin to instantly manifest the reality of your purpose for living, Emblemed and empowered with full of Zeal, Passion and Fruitfulness, Genuinely ready for all the good works God has designed you to accomplish – Loving God with all your heart, soul and strength and loving others through your service of obedience to his Commission, Praying, Evangelizing, Discipling, Equipping and living a lasting fruit to the Glory of God. Our focus will be what it does take to be dressed, ready for service from your call to salvation to your call to service, Exploring your Meditational life, Family Life and a life of Obedience to His Command and Commission. AS YOU RESPONDING TO GOD’S COMMAND AND COMMISSION